Intrinsic Value of S&P & Nasdaq Contact Us

Lipocine Inc. LPCN NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
48/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$15.00
+485.9%

Lipocine Inc. (LPCN) has 19 known insider and institutional holders on record. The largest holder is VIZEL ISRAEL MENAHEM with 3,000,000 shares. Other notable holders include VISIUM BALANCED MASTER FUND, LTD. and ELAN CORP PLC.

Over the last 12 months, insiders have made 11 transactions in LPCN stock — 11 buys (valued at $705.17K) and 0 sells (valued at RSU Award). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.

LPCN Insider Ownership

Top Holder
VIZEL ISRAEL MENAHEM
3,000,000 shares
Buys (12 mo)
11
$705.17K value
Sells (12 mo)
0
$0.00 value
12-Month Transaction Activity
Buy 100%
Sell 0%
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Vizel Israel Menahem 10 Percent Owner, Officer: President, Treasurer and Sec'y 3,000,000 2012-02-14
100%
2 Visium Balanced Master Fund, Ltd. 10 Percent Owner 1,206,000 2013-11-25
40%
3 Elan Corp Plc 10 Percent Owner 800,394 2013-08-02
27%
4 Ucb Manufacturing Ireland Ltd. 10 Percent Owner 580,402 2013-08-15
19%
5 Brown Morgan R Chief Financial Officer 176,000 2021-12-08
6%
6 Higuchi John W. Director 163,797 2026-04-06
5%
7 Patel Mahesh V. Chief Executive Officer 160,679 2026-04-06
5%
8 Nomikos George Chief Medical Officer 125,000 2022-11-08
4%
9 Fogarty Krista Principal Accounting Officer 40,146 2025-12-19
1%
10 Mattila Jyrki Chief Business Officer 15,000 2017-01-30
1%
11 Simmons Gerald T Chief Business Officer 11,942 2014-08-15
0%
12 Fink Jeffrey Arvin Director 11,526 2025-06-05
0%
13 Ono Richard Dana Director 11,526 2025-06-05
0%
14 Venkateshwaran Srinivasan VP Randd 10,363 2014-08-15
0%
15 Hill Stephen A Director 7,500 2020-12-17
0%
16 Jene Jill M. Director 7,174 2025-06-05
0%
17 Papapetropoulos Spyros Director 7,174 2025-06-05
0%
18 Bass Gregory Brooks Chief Commercial Officer 5,625 2018-01-02
0%
19 Merrell Robert K. VP Finance 4,000 2013-12-11
0%
Recent Transactions (last 12 months)
Date Name Role Type Shares Price Value
2026-04-06 Higuchi John W. Director Informative Buy 123,000 $2.05 $252.15K
2026-04-06 Patel Mahesh V. Chief Executive Officer Informative Buy 25,000 $2.03 $50.75K
2026-04-02 Patel Mahesh V. Chief Executive Officer Informative Buy 25,000 $2.02 $50.5K
2026-01-02 Patel Mahesh V. Chief Executive Officer RSU Award 25,000 $8.00 $200K
2025-12-18 Fogarty Krista Principal Accounting Officer RSU Award 20,786 $4.20 $87.3K
2025-12-18 Patel Mahesh V. Chief Executive Officer RSU Award 8,629 $4.20 $36.24K
2025-06-04 Papapetropoulos Spyros Director RSU Award 1,764 $3.20 $5.64K
2025-06-04 Jene Jill M. Director RSU Award 1,764 $3.20 $5.64K
2025-06-04 Ono Richard Dana Director RSU Award 1,764 $3.20 $5.64K
2025-06-04 Fink Jeffrey Arvin Director RSU Award 1,764 $3.20 $5.64K
2025-06-04 Higuchi John W. Director RSU Award 1,764 $3.20 $5.64K
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message